Moderna Spikevax COVID-19 Vaccine from United States
Moderna Spikevax is an mRNA-based COVID-19 vaccine encoding the SARS-CoV-2 spike protein to elicit an immune response. It is supplied in prefilled syringes for retail sale, fitting the criteria for immunological products.
Duty Rate — United States → Canada
0%
Import Tips
• Secure a Health Canada import authorization
• Maintain cold-chain records for CBSA inspection
• Declare the product's mRNA technology and retail packaging